Population pharmacokinetics and pharmacodynamics of dalfampridine-ER in healthy volunteers and in patients with multiple sclerosis

By Weir Scott   Gao Yuying   Henney Herbert R.  

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1637-1645

Informa Healthcare

Access to resources Recommend Favorite

Dalfampridine: a brief review of its mechanism of action and efficacy as a treatment to improve walking in patients with multiple sclerosis

By Dunn Jeffrey   Blight Andrew  

Current Medical Research and Opinion, Vol. 27, Iss. 7, 2011-07 ,pp. : 1415-1423

Informa Healthcare

Access to resources Recommend Favorite

A Pharmacokinetic and Pharmacodynamic Comparison of Immediate-Release Metoprolol and Extended-Release Metoprolol CR/XL in Patients with Suspected Acute Myocardial Infarction: A Randomized, Open-Label Study

By  

Cardiology, Vol. 127, Iss. 2, 2013-11 ,pp. : 73-82

Karger

Access to resources Recommend Favorite

Gait characteristics of multiple sclerosis patients in the absence of clinical disability

By Nogueira Leandro Alberto Calazans   Teixeira Luciano  

Disability and Rehabilitation, Vol. 35, Iss. 17, 2013-08 ,pp. : 1472-1478

Informa Healthcare

Access to resources Recommend Favorite

Lack of clinical manifestation of hereditary haemochromatosis in South African patients with multiple sclerosis

By Kotze Maritha   de Villiers J   Warnich Louise   Schmidt Stephen   Carr Jonathan   Mansvelt Erna   Fourie Elba   van Rensburg Susan  

Metabolic Brain Disease, Vol. 21, Iss. 2-3, 2006-09 ,pp. : 105-116

Springer Publishing Company

Access to resources Recommend Favorite